...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trial

That would be my guess too and i suspect that there will be an uodate on the prostrate cancer trial progress. Would like to know how many patients are  still in the trial, whether it is being extended and some indication of how they are doing.

Share
New Message
Please login to post a reply